Search
forResearch 10 of 1000+
- High Response Rate to Bexxar in Advanced Stage Prior Treatment-Resistant Follicular Lymphoma
- 43755 Rapid Reduction and Strict Complete Response in Itch With Oral Difelikefalin in Subjects With Notalgia Paresthetica and Moderate-to-Severe Pruritus
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Ki-67 Levels and Their Association With Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Prospective Observational Study
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- PUVA treatment of alopecia areata totalis and universalis: A retrospective study
- A systematic review of pulse steroid therapy for alopecia areata
- Teledermatology: An updated overview of clinical applications and reimbursement policies
Community 1 of 45
All community results →Learn
— no results
Try a deeper search in learn →